RT Journal Article
SR Electronic
T1 Higher proportions of CD39+ tumor-resident cytotoxic T cells predict recurrence-free survival in patients with stage III melanoma treated with adjuvant immunotherapy
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e004771
DO 10.1136/jitc-2022-004771
VO 10
IS 6
A1 Attrill, Grace Heloise
A1 Owen, Carina N
A1 Ahmed, Tasnia
A1 Vergara, Ismael A
A1 Colebatch, Andrew J
A1 Conway, Jordan W
A1 Nahar, Kazi J
A1 Thompson, John F
A1 Pires da Silva, Ines
A1 Carlino, Matteo S
A1 Menzies, Alexander M
A1 Lo, Serigne
A1 Palendira, Umaimainthan
A1 Scolyer, Richard A
A1 Long, Georgina V
A1 Wilmott, James S
YR 2022
UL http://jitc.bmj.com/content/10/6/e004771.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.